Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021

BACKGROUND: The risk of SARS-CoV-2 (re-)infection remains present given waning of vaccine-induced and infection-acquired immunity, and ongoing circulation of new variants. AIM: To develop a method that predicts virus neutralisation and disease protection based on variant-specific antibody measuremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Woudenberg, Tom, Pinaud, Laurie, Garcia, Laura, Tondeur, Laura, Pelleau, Stéphane, De Thoisy, Alix, Donnadieu, Françoise, Backovic, Marija, Attia, Mikaël, Hozé, Nathanael, Duru, Cécile, Koffi, Aymar Davy, Castelain, Sandrine, Ungeheuer, Marie-Noelle, Fernandes Pellerin, Sandrine, Planas, Delphine, Bruel, Timothée, Cauchemez, Simon, Schwartz, Olivier, Fontanet, Arnaud, White, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288827/
https://www.ncbi.nlm.nih.gov/pubmed/37347417
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.25.2200681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288827/
https://www.ncbi.nlm.nih.gov/pubmed/37347417
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.25.2200681

Ejemplares similares